Drug name - Vancomycin
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10188697 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(13 years from now) | |
| US10039804 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(13 years from now) | |
| US11000567 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(13 years from now) | |
| US10849956 | XELLIA PHARMS APS | Glycopeptide compositions |
Nov, 2035
(13 years from now) | |
Drugs and Companies using VANCOMYCIN ingredient
Treatment: Method of treating bacterial infections
Dosage: SOLUTION;INTRAVENOUS, ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5GM/100ML (50MG/ML) | SOLUTION;INTRAVENOUS, ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.